China NMPA Product Recall - Central venous catheter kit for hemodialysis

On July 4, 2023, the National Medical Products Administration (NMPA) announced a voluntary Class I recall initiated by Covidien LLC, in conjunction with its subsidiary, Covidien Medical Devices International Trading (Shanghai) Co., Ltd. This critical action involves specific Central Venous Catheter Kits for Hemodialysis. The core issue stemmed from a manufacturing deficiency: an incorrect mixing ratio of the silicone-based lubricant applied to the catheter tip. This error led to an overly thick coating, which consequently caused the catheter tip to become clogged, potentially compromising the device's intended function. The Class I classification signifies that there is a high probability of serious adverse health consequences or even death if the defective product is used. Covidien LLC is executing this recall to mitigate potential patient safety risks arising from this malfunction. Comprehensive details regarding the affected product models are provided in the "Medical Device Recall Event Report Form." This regulatory oversight by the NMPA emphasizes the importance of stringent quality control in medical device manufacturing and the immediate action required to protect public health when defects are identified.